Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...
A new study highlights the impressive results. The detection threshold of the cascade-engineered devices has improved ...
Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.
Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...
GSK has announced positive headline interim analysis outcomes from a Phase III trial, which is evaluating Blenrep (belantamab ...
Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...
I visited an orthopedic clinic where they took an X-ray. They saw a tumor on my sacrum, which led to blood work and a bone marrow biopsy. The week after the race, I learned I had multiple myeloma, a ...
Multiple myeloma is a type of cancer where plasma cells in bone marrow replicate out of control. Doctors use the acronym CRAB to diagnose myeloma by identifying four symptoms. The National Cancer ...
DESTIN, Fla. (WJHG/WECP) - The Okaloosa Sheriff’s Office has released details about a crash that reportedly left multiple area students injured. A report from the sheriff’s office stated the ...
(WNDU) - Multiple school districts in southwest Michigan say they briefly went on lockdown on Thursday due to a swatting call. “Swatting” involves making a false emergency call to prompt a ...
Historically, we evaluated myeloma through monoclonal proteins or free light chains in the blood and urine and percentage of plasma cells in the bone marrow. But this is like the iceberg ...
Credit: Michael Vi/Shutterstock The European label for Johnson and Johnson Innovation Medicine’s (J&J) Darzalex (daratumumab) has been expanded to include patients with newly diagnosed multiple ...